These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 36281949)

  • 1. Regulators of epigenetic change in ferroptosis‑associated cancer (Review).
    Wu J; Zhu S; Wang P; Wang J; Huang J; Wang T; Guo L; Liang D; Meng Q; Pan H
    Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis regulation by methylation in cancer.
    Hao M; Jiang Y; Zhang Y; Yang X; Han J
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188972. PubMed ID: 37634887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis: molecular mechanisms and health implications.
    Tang D; Chen X; Kang R; Kroemer G
    Cell Res; 2021 Feb; 31(2):107-125. PubMed ID: 33268902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FERREG: ferroptosis-based regulation of disease occurrence, progression and therapeutic response.
    Zhou Y; Chen Z; Yang M; Chen F; Yin J; Zhang Y; Zhou X; Sun X; Ni Z; Chen L; Lv Q; Zhu F; Liu S
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38742521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.
    Lee J; Roh JL
    Cell Oncol (Dordr); 2023 Dec; 46(6):1605-1623. PubMed ID: 37438601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor.
    Cheng Y; Xie Y; Chen Y; Liu X
    Oxid Med Cell Longev; 2021; 2021():8854790. PubMed ID: 33574983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases.
    Lan T; Sun TT; Wei C; Cheng T; Yang F; Zhang JN; Li Q
    Mol Neurobiol; 2023 Jul; 60(7):3584-3599. PubMed ID: 36847936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression.
    Wu Y; Zhang S; Gong X; Tam S; Xiao D; Liu S; Tao Y
    Mol Cancer; 2020 Feb; 19(1):39. PubMed ID: 32103754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy.
    Maru D; Hothi A; Bagariya C; Kumar A
    Curr Cancer Drug Targets; 2022; 22(3):234-244. PubMed ID: 35152865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response.
    Yao Y; Shi Y; Gao Z; Sun Y; Yao F; Ma L
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C95-C103. PubMed ID: 35613358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.
    Zhu J; Xiong Y; Zhang Y; Wen J; Cai N; Cheng K; Liang H; Zhang W
    Oxid Med Cell Longev; 2020; 2020():8810785. PubMed ID: 33425217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ferroptosis in gastrointestinal tumors: From mechanisms to therapies.
    Si C; Zhou X; Deng J; Ye S; Kong L; Zhang B; Wang W
    Cell Biol Int; 2022 Jul; 46(7):997-1008. PubMed ID: 35476364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach.
    Xia X; Fan X; Zhao M; Zhu P
    Curr Gene Ther; 2019; 19(2):117-124. PubMed ID: 31264548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ferroptosis in central nervous system damage diseases.
    Li M; Jin S; Zhu X; Xu J; Cao Y; Piao H
    PeerJ; 2024; 12():e16741. PubMed ID: 38313006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs and ferroptosis: potential implications for cancer therapy.
    Balihodzic A; Prinz F; Dengler MA; Calin GA; Jost PJ; Pichler M
    Cell Death Differ; 2022 Jun; 29(6):1094-1106. PubMed ID: 35422492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review).
    Li J; Xian L; Zhu Z; Wang Y; Zhang W; Zheng R; Xue W; Li J
    Int J Mol Med; 2023 Oct; 52(4):. PubMed ID: 37594127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered iron metabolism as a target for ferroptosis induction in head and neck cancer.
    Lee J; Roh JL
    Cell Oncol (Dordr); 2023 Aug; 46(4):801-810. PubMed ID: 36811720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.
    Zhou S; Liu J; Wan A; Zhang Y; Qi X
    J Hematol Oncol; 2024 Apr; 17(1):22. PubMed ID: 38654314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations.
    Zhou N; Bao J
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32219413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying events.
    Bertrand RL
    Med Hypotheses; 2017 Apr; 101():69-74. PubMed ID: 28351498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.